How Johnson & Johnson Uses Generative AI to Address Health Care BiasesHow Johnson & Johnson Uses Generative AI to Address Health Care Biases
Video Interview with Pablo Damasceno, Principal Scientist at Johnson & Johnson Innovative Medicine
1 Min Read
![Pablo Damasceno, Principal Scientist at Johnson & Johnson Innovative Medicine Pablo Damasceno, Principal Scientist at Johnson & Johnson Innovative Medicine](https://eu-images.contentstack.com/v3/assets/blt31d6b0704ba96e9d/bltb3ac18fb0fbded8f/65788634172916040ae828f6/Pablo_Damasceno_Johnson_&_Johnson.png?width=1280&auto=webp&quality=95&format=jpg&disable=upscale)
Pablo Damasceno, Principal Scientist at Johnson & Johnson Innovative Medicine. Informa Tech
In this interview from the AI Summit New York, Informa Tech editorial director Chuck Martin talks to Pablo Damasceno, Principal Scientist at Johnson & Johnson Innovative Medicine. Damasceno explains how Johnson & Johnson uses generative AI and diffusion models to address bias and improve equity in health care.
Read more about:
AsiaAbout the Author
Sign Up for the Newsletter
The most up-to-date news and insights into the latest emerging technologies ... delivered right to your inbox!
You May Also Like